Edition:
United Kingdom

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

24.11USD
23 Feb 2018
Change (% chg)

$2.10 (+9.54%)
Prev Close
$22.01
Open
$22.29
Day's High
$24.11
Day's Low
$21.55
Volume
115,886
Avg. Vol
48,597
52-wk High
$28.56
52-wk Low
$12.04

Select another date:

Wed, Feb 21 2018

BRIEF-G1 Therapeutics Qtrly Net Loss Per Share $0.60

* G1 THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS

BRIEF-Medimmune Ventures Sells 133,906 Shares Of G1 Therapeutics Inc's Common Stock On Dec 1

* MEDIMMUNE VENTURES INC REPORTS SALE OF 133,906 SHARES OF G1 THERAPEUTICS INC'S COMMON STOCK ON DEC 1 AT $19.75 PER SHARE - SEC FILING Source text: (http://bit.ly/2iVgOvs) Further company coverage:

BRIEF-G1 Therapeutics And AstraZeneca Enter Clinical Trial Collaboration In Non-Small Cell Lung Cancer

* G1 THERAPEUTICS AND ASTRAZENECA ENTER CLINICAL TRIAL COLLABORATION IN NON-SMALL CELL LUNG CANCER

BRIEF-G1 Therapeutics Inc appoints Barclay (Buck) Phillips as CFO and SVP, corporate development​

* G1 Therapeutics Inc - appoints barclay (buck) phillips as chief financial officer and senior vice president, corporate development​

BRIEF-G1 Therapeutics qtrly ‍loss per share $0.55

* G1 therapeutics reports third quarter 2017 financial results and recent operational highlights

Select another date: